Obesity Management Market Share Analysis, Strategies, Revenue and Forecasts to 2027


Posted November 9, 2021 by diksha123

Sedentary lifestyle, and overeating are often linked with obesity. Obesity is now a global issue as it is prevalent in high, middle and low-income countries
 
Global Obesity Management Market to Demonstrate an Above-Average Growth Rate over 2022

Sedentary lifestyle, and overeating are often linked with obesity. Obesity is now a global issue as it is prevalent in high, middle and low-income countries. Prevalence of obesity has increased significantly in recent years and thereby driving the demand for its treatment and management. The global obesity management market is expected to exhibit a compound annual growth rate (CAGR) of 8.4% during 2015-2022 finds Market Research Future (MRFR) in its latest study. In addition, the market is expected to surpass a valuation of USD 6 Bn towards the end of forecast period.

Obesity is a highly complex disorder and requires rigorous monitoring. Moreover, there is severe scepticism over obesity treatment options and medications owing to risk of side-effects and outcomes. This is promoting pharmaceutical companies to focus on R&D pipelines. Obesity is often cited as catalyst for development of others chronic diseases such as heart diseases, hypertension, diabetes, among others. Nevertheless, advances in healthcare technology, helped in developing more effective and safer obesity management solutions.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/2690

Competitive Landscape

Some of the prominent companies operating in the global obesity management market include GlaxoSmithKline plc. (UK), Herbalife Ltd. (U.S.), Ethicon, Inc. (U.S.), Merck Sharp & Dohme Corp (US), F. Hoffmann-La Roche Ltd (Switzerland), Apollo Endosurgery (U.S.), Pfizer Inc. (US), and AstraZeneca (UK).

Segmental Overview

The segmental analysis of the global Obesity Management Market Size has been conducted on the basis of prescription, surgery and lifestyle changes.

Based on prescription, the market has been segmented into lorcaserin (Belviq), buproprion and naltrexone (Contrave), liraglutide (Saxenda), orlistat (Xenical), phentermine and topiramate (Qsymia) and others. Based on surgery, the market has been segmented into Biliopancreatic diversion with duodenal switch, Laparoscopic adjustable gastric banding (LAGB), Gastric bypass surgery and others. Based on lifestyle changes, the market has been segmented into exercise, dietary changes and others.

Global Obesity Management Market: Regional Segmentation

Key regions discussed in the MRFR’s report include Americas, Asia Pacific (APAC), and Europe. North America dominates the global obesity management market. High healthcare expenditure and a readily accessible healthcare support systems are among the key factors supporting the market growth in North America. A significant number of Americans are affected by obesity and its associated disorders. Europe ranks second in the pecking order. Well established healthcare system and high awareness level are propelling the market in Europe. The market growth in Asia-Pacific is also expected to be impressive during the forecast period. The region displays significant market potential; increased focus on improving healthcare services, awareness campaigns initiated by governments and improved healthcare penetration indicates towards a favourable climate for market players operating in the region. Countries such as China, Taiwan, India, Japan, South Korea are registering a higher number of over-nourishment cases. Increasing disposable income, and lifestyle changes are factors that can be associated with rise in prevalence of obesity. Favourable policies, faster adoption of advanced healthcare technologies, expanding R&D investment corpus is providing an impetus. Growing per capita income in countries such as China and India along with the expanding patient pool make them attractive investment destinations.

Get Full Report at https://www.marketresearchfuture.com/reports/obesity-management-market-2690

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By [email protected]
Phone 06468459312
Business Address Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,,
https://www.marketresearchfuture.com
Country India
Categories Health
Last Updated November 9, 2021